Bo Fu

1.2k total citations
54 papers, 882 citations indexed

About

Bo Fu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Bo Fu has authored 54 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Bo Fu's work include T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers) and Cancer-related molecular mechanisms research (6 papers). Bo Fu is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers) and Cancer-related molecular mechanisms research (6 papers). Bo Fu collaborates with scholars based in China, United Kingdom and United States. Bo Fu's co-authors include Lu‐Gang Yu, Jonathan M. Rhodes, Qicheng Zhao, Jianqiong Zhang, Hans H. Wandall, Chen Chen, Wenqiang Tang, Hannah Barrow, Johannes W. Pedersen and Anqi Zhang and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and Brain Research.

In The Last Decade

Bo Fu

49 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Fu China 16 333 328 166 155 122 54 882
Majid Zamani Iran 13 388 1.2× 130 0.4× 151 0.9× 157 1.0× 79 0.6× 28 892
Antonella Coli Italy 16 225 0.7× 210 0.6× 224 1.3× 121 0.8× 124 1.0× 68 990
Christine Shen United States 11 517 1.6× 167 0.5× 116 0.7× 94 0.6× 228 1.9× 27 1.2k
Nicholas R. Hum United States 21 524 1.6× 169 0.5× 316 1.9× 183 1.2× 239 2.0× 50 1.1k
Weijun Huang China 21 576 1.7× 151 0.5× 137 0.8× 187 1.2× 35 0.3× 52 1.1k
Veronica Lisi Italy 14 418 1.3× 240 0.7× 249 1.5× 131 0.8× 50 0.4× 29 1.2k
Stefania Lymperi Greece 15 352 1.1× 270 0.8× 206 1.2× 96 0.6× 64 0.5× 26 1.1k
Maria Antonietta Mazzola United States 15 352 1.1× 114 0.3× 105 0.6× 238 1.5× 47 0.4× 37 760
Min Hu China 13 320 1.0× 121 0.4× 147 0.9× 144 0.9× 90 0.7× 46 751

Countries citing papers authored by Bo Fu

Since Specialization
Citations

This map shows the geographic impact of Bo Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Fu more than expected).

Fields of papers citing papers by Bo Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Fu. The network helps show where Bo Fu may publish in the future.

Co-authorship network of co-authors of Bo Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Fu. A scholar is included among the top collaborators of Bo Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Fu. Bo Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Song, ­Jun Li­, Di Zhang, et al.. (2025). Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier. Cancer Biology and Medicine. 22(6). 1–24. 2 indexed citations
2.
Li, Min, Jiawei Li, Jun Li, et al.. (2025). NSUN2-mediated m5C hypermethylation of hsa_circ_0004516 promotes breast cancer brain metastasis by activating AKT signaling. Non-coding RNA Research. 14. 177–190.
3.
Wang, Yingying, Dongyan Zhang, Xueping Huang, et al.. (2025). From heterogeneity to prognosis: understanding the complexity of tertiary lymphoid structures in tumors. Molecular Biology Reports. 52(1). 197–197.
4.
Shi, Li, et al.. (2025). Research hotspots and frontiers in the tumor microenvironment of colorectal cancer: a bibliometric study from 2014 to 2024. Frontiers in Oncology. 15. 1525280–1525280. 1 indexed citations
5.
Wen, Nachuan, Yao Lu, Yuting Zhuo, et al.. (2025). Enhancing T-Cell Infiltration and Immunity in Solid Tumors via DNA Nanolinker-Mediated Monocyte Hitchhiking. Journal of the American Chemical Society. 147(11). 9800–9809. 6 indexed citations
6.
Huang, Xueping, et al.. (2024). Decoding PTEN: from biological functions to signaling pathways in tumors. Molecular Biology Reports. 51(1). 1089–1089. 2 indexed citations
7.
Pan, Li, et al.. (2024). Characterisation of the novel HLA‐A*24:630 allele by sequencing‐based typing. HLA. 104(2). e15650–e15650. 2 indexed citations
8.
Li, Min, Jun Li, Xuan Li, et al.. (2024). Comprehensive analysis of RNA-5-methylcytosine modification in breast cancer brain metastasis. Future Oncology. 20(37). 2993–3008. 1 indexed citations
9.
Zhuo, Yuting, Bo Fu, Ruizi Peng, et al.. (2023). Aptamer-based expansion microscopy platform enables signal-amplified imaging of dendritic spines. Talanta. 260. 124541–124541. 2 indexed citations
10.
Pan, Li, Wenqiang Tang, Anqi Zhang, Wei Liu, & Bo Fu. (2022). Characterization of the novel HLA‐B*15:504:02 allele by sequencing‐based typing. HLA. 101(5). 537–538. 1 indexed citations
11.
Chaudhry, Imran B., Muhammad Omair Husain, Ameer B. Khoso, et al.. (2021). Correction: A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis. Translational Psychiatry. 11(1). 1 indexed citations
12.
Wang, Jimin, et al.. (2021). Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis. Epigenomics. 13(14). 1113–1128. 14 indexed citations
13.
Chaudhry, Imran B., Muhammad Omair Husain, Ameer B. Khoso, et al.. (2020). A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis. Translational Psychiatry. 10(1). 415–415. 40 indexed citations
14.
Tang, Wenqiang, Anqi Zhang, Pan Li, et al.. (2020). An Asymptomatic SARS-CoV-2-Infected Infant With Persistent Fecal Viral RNA Shedding in a Family Cluster: A Rare Case Report. Frontiers in Medicine. 7. 8 indexed citations
15.
Guo, Qianqian, Wang Liu, Aihua Zhang, et al.. (2019). Oral cancer-associated tertiary lymphoid structures: gene expression profile and prognostic value. Clinical & Experimental Immunology. 199(2). 172–181. 52 indexed citations
16.
Vastesaeger, Nathan, Howard Amital, Karel Pavelká, et al.. (2016). Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab. Lara D. Veeken. 55(8). 1466–1476. 18 indexed citations
18.
Fu, Bo, Li Dong, & Jian Yang. (2014). Iatrogenic innominate arteriovenous fistula repaired with the stent-graft. Journal of Thoracic and Cardiovascular Surgery. 148(6). 3234–3235.
19.
Dong, Li, et al.. (2012). Clinical analysis of concomitant valve replacement and bipolar radiofrequency ablation in 191 patients. Journal of Thoracic and Cardiovascular Surgery. 145(4). 1013–1017. 11 indexed citations
20.
Barrow, Hannah, Xiuli Guo, Hans H. Wandall, et al.. (2011). Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium. Clinical Cancer Research. 17(22). 7035–7046. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026